Haverford Trust Co Acquires Shares of 20,051 CVS Health Corporation $CVS

Key Points

• Haverford Trust Co. acquired 20,051 CVS Health shares during the second quarter, valued at approximately $2.07 million. Institutional investors and hedge funds collectively own 80.66% of CVS stock.
• Analysts maintain a favorable outlook, with 22 Buy ratings and two Hold ratings. CVS has an overall “Moderate Buy” consensus rating and an average price target of $107.17.
• CVS reported quarterly earnings of $2.58 per share, exceeding estimates of $1.87, while revenue rose 7.3% year over year to $106.10 billion. The company also pays an annualized dividend of $2.66 per share, yielding about 2.9%.

Haverford Trust Co bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 20,051 shares of the pharmacy operator's stock, valued at approximately $2,074,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Handelsbanken Fonder AB grew its stake in CVS Health by 83.6% during the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator's stock worth $112,729,000 after buying an additional 496,124 shares in the last quarter. State Street Corp raised its position in shares of CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator's stock valued at $4,776,182,000 after buying an additional 1,245,457 shares in the last quarter. Legal & General Group Plc lifted its holdings in shares of CVS Health by 0.3% during the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator's stock worth $738,777,000 after acquiring an additional 31,249 shares during the period. Deutsche Bank AG lifted its holdings in shares of CVS Health by 28.4% during the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator's stock worth $370,333,000 after acquiring an additional 1,031,998 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $49,622,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CVS. Wall Street Zen upgraded shares of CVS Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 8th. DA Davidson raised their target price on CVS Health from $80.00 to $100.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Morgan Stanley lifted their price target on CVS Health from $106.00 to $111.00 and gave the company an "overweight" rating in a research note on Thursday, June 4th. Robert W. Baird set a $107.00 price target on CVS Health in a report on Thursday, August 6th. Finally, HSBC restated a "hold" rating and set a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $107.17.

CVS Health Price Performance

Shares of NYSE:CVS opened at $93.01 on Friday. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The company has a market cap of $118.96 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61. The firm has a 50 day simple moving average of $102.02 and a 200 day simple moving average of $88.86.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio is presently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source